AdaptHealth appoints Suzanne Foster CEO effective May 20; Richard Barasch to step down
AdaptHealth Corp.
Suzanne Foster, former President of Beckman Coulter Life Sciences (Danaher), named CEO and board member effective May 20, 2024.
Interim CEO and Chairman Richard Barasch will cease as interim CEO on May 20, remain Chairman until June 30, then resign as director and serve as special advisor.
CEO employment agreement provides $900,000 base salary, target annual bonus of 120% of base, and inducement RSUs worth $4.9M plus $1M with multi-year vesting.
CFO Jason Clemens' employment amended to increase severance base salary payments from 12 to 18 months on qualifying termination.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.